Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
- 1 December 1992
- Vol. 71 (7), 1093-1102
- https://doi.org/10.1016/s0092-8674(05)80059-5
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- Heat-stable antigen is a costimulatory molecule for CD4 T cell growth.The Journal of Experimental Medicine, 1992
- CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.The Journal of Experimental Medicine, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodiesCancer Immunology, Immunotherapy, 1990
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989
- Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfectionNature, 1985
- Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationNature, 1984
- Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte ConceptAnnual Review of Immunology, 1983